Background
Immune suppression is one of the hallmarks by which head and neck squamous cell carcinoma (HNSCC) develops a tumor permissible environment [1] . Semaphorin 4D (Sema4D), known for its various developmental, physiological and pathological effects, was recently shown to play a role in regulating the immune system [2] . Sema4D is expressed in many epithelial tumors including HNSCC [3] ; yet, the effect of Sema4D on modulating the inflammatory profile within the tumor microenvironment of HNSCC remains to be elucidated.
Methods
Human HNSCC cell lines HN6 and HN13 were used to study the effect of Sema4D produced in tumor conditioned media (TCM), on myeloid and T cells separated from human peripheral blood mononuclear cells (PBMC) of healthy donors. Neutralizing anti-Sema4D antibody and Sema4D immune depletion from the TCM were carried out. Lentivirus shRNA was also used to knock down Sema4D in HNSCC-HN6 cells. 
Results

Treatment
Conclusion
This study describes a novel immunosuppressive mechanism for HNSCC through Sema4D induction of MDSCs. Collectively; our work highlights the therapeutic potential of Sema4D inhibition as a strategy to improve the efficacy of immunotherapy in HNSCC. 
